Levodopa vs Tofacitinib

## Levodopa vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Levodopa** and **Tofacitinib**.

## Mechanism of Action

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Levodopa — 1.5 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Levodopa — C9H11NO4; Tofacitinib — C16H20N6O.

**Molecular Weight**: Levodopa — 197.1880 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Levodopa — Small molecule; Tofacitinib — Small molecule.